BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 125 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $48,000 | +140.0% | 10,000 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $20,000 | -42.9% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $35,000 | +20.7% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $29,000 | -23.7% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $38,000 | -53.1% | 10,000 | 0.0% | 0.00% | -55.6% |
| Q1 2019 | $81,000 | 0.0% | 10,000 | 0.0% | 0.01% | -18.2% |
| Q4 2018 | $81,000 | -1.2% | 10,000 | -7.4% | 0.01% | +22.2% |
| Q3 2018 | $82,000 | +32.3% | 10,800 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $62,000 | +19.2% | 10,800 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $52,000 | -8.8% | 10,800 | -7.3% | 0.01% | -14.3% |
| Q4 2017 | $57,000 | -8.1% | 11,650 | -2.9% | 0.01% | -12.5% |
| Q3 2017 | $62,000 | -7.5% | 12,000 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $67,000 | -33.7% | 12,000 | 0.0% | 0.01% | -35.7% |
| Q1 2017 | $101,000 | -15.8% | 12,000 | -36.8% | 0.01% | -22.2% |
| Q4 2016 | $120,000 | +42.9% | 19,000 | 0.0% | 0.02% | +38.5% |
| Q3 2016 | $84,000 | +55.6% | 19,000 | 0.0% | 0.01% | +44.4% |
| Q2 2016 | $54,000 | +1.9% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $53,000 | -73.0% | 19,000 | 0.0% | 0.01% | -74.3% |
| Q4 2015 | $196,000 | -9.7% | 19,000 | 0.0% | 0.04% | -14.6% |
| Q3 2015 | $217,000 | -23.3% | 19,000 | 0.0% | 0.04% | -16.3% |
| Q2 2015 | $283,000 | – | 19,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |